Hemorrhage remains the leading cause of maternal death worldwide. Tranexamic acid has been
shown to reduce rates of hemorrhage when given prophylactically prior to cesarean delivery.
It has also been shown to be an effective treatment in response to hemorrhage after a vaginal
delivery. The aim of this study is to assess the impact of TXA on hemorrhage rates when given
prophylactically prior to all deliveries.